CD7 and acute lymphoblastic leukemia: Cooper and colleagues used a similar mechanism to create CD7 CAR T-cells with a disrupted TCR alpha chain which successfully killed human T-ALL cell lines in vitro and in vivo without evidence of xenograft model GVHD [39].